Moderna’s mRNA cancer vaccine shows promise in preliminary study

A custom-made Moderna Inc. vaccine mixed with a Merck & Co. most cancers drug helped thrust back the recurrence of the pores and skin most cancers melanoma after surgical procedure in sufferers in a mid-stage medical trial, the businesses stated.